Management Change27 Oct 2026, 02:55 pm
Fischer Medical Ventures: Appoints Independent Director to Singapore Subsidiary
AI Summary
Fischer Medical Ventures Limited announced the appointment of Mr. Chan Sing En as an Independent Director to the Board of Directors of its material wholly owned subsidiary, FMV Global Innovations Pte. Ltd., Singapore. The appointment is effective from October 27, 2026. Mr. Chan Sing En brings over three decades of experience in private equity, corporate finance, and operational turnarounds across Southeast Asia and Australia. He currently serves as Principal and Director of SovCapital Pte Ltd and is on the advisory board of FTAG Investment Bank. He is not related to any directors of Fischer Medical Ventures and is not debarred from holding a directorship.
Key Highlights
- Appointment of an Independent Director to a material wholly owned subsidiary.
- Mr. Chan Sing En brings extensive experience in private equity and corporate finance.
- The appointment is effective from October 27, 2026.
- Mr. Chan Sing En has no disclosed relationship with existing directors.
Price Impact
More from FISCHER